MX381655B - Metodo para preparar vesiculas con gradiente de ph de transmembrana. - Google Patents

Metodo para preparar vesiculas con gradiente de ph de transmembrana.

Info

Publication number
MX381655B
MX381655B MX2017014130A MX2017014130A MX381655B MX 381655 B MX381655 B MX 381655B MX 2017014130 A MX2017014130 A MX 2017014130A MX 2017014130 A MX2017014130 A MX 2017014130A MX 381655 B MX381655 B MX 381655B
Authority
MX
Mexico
Prior art keywords
vesicles
buffer
transmembrane
gradient
osmolarity
Prior art date
Application number
MX2017014130A
Other languages
English (en)
Spanish (es)
Other versions
MX2017014130A (es
Inventor
Jean-Christophe Leroux
Valentina Agostoni
Vincent Forster
Original Assignee
Versantis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Versantis AG filed Critical Versantis AG
Publication of MX2017014130A publication Critical patent/MX2017014130A/es
Publication of MX381655B publication Critical patent/MX381655B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2017014130A 2015-05-04 2016-05-03 Metodo para preparar vesiculas con gradiente de ph de transmembrana. MX381655B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15166247 2015-05-04
PCT/EP2016/059912 WO2016177741A1 (en) 2015-05-04 2016-05-03 Method for preparing transmembrane ph-gradient vesicles

Publications (2)

Publication Number Publication Date
MX2017014130A MX2017014130A (es) 2018-07-06
MX381655B true MX381655B (es) 2025-03-13

Family

ID=53052718

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017014130A MX381655B (es) 2015-05-04 2016-05-03 Metodo para preparar vesiculas con gradiente de ph de transmembrana.

Country Status (11)

Country Link
US (2) US11376218B2 (https=)
EP (1) EP3291797B1 (https=)
JP (1) JP6715265B2 (https=)
CN (1) CN107750156B (https=)
AU (1) AU2016256979B2 (https=)
DK (1) DK3291797T3 (https=)
ES (1) ES2826896T3 (https=)
MX (1) MX381655B (https=)
PT (1) PT3291797T (https=)
RU (1) RU2717824C2 (https=)
WO (1) WO2016177741A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016256979B2 (en) * 2015-05-04 2021-01-28 Genfit Method for preparing transmembrane pH-gradient vesicles
KR20230110284A (ko) 2020-11-17 2023-07-21 장피트 간부전 치료 방법
EP4618954A1 (en) 2022-11-16 2025-09-24 Genfit Use of transmembrane ph gradient liposomes for treating hyperammonemic crisis associated with inborn errors of metabolism
WO2026078189A1 (en) 2024-10-11 2026-04-16 Genfit Treating endotoxemia with a liposomal suspension
WO2026078188A1 (en) 2024-10-11 2026-04-16 Genfit Reducing a pathological blood level of bile acids with a liposome suspension

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5297024A (en) 1976-02-09 1977-08-15 Nissan Motor Co Ltd Air fuel ratio controller
FR2521565B1 (fr) 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
FR2553002B1 (fr) 1983-10-06 1992-03-27 Centre Nat Rech Scient Procede perfectionne d'obtention de liposomes unilamellaires de diametres eleves, leur application pharmacologique pour l'encapsulage d'un principe actif en vue de son administration extemporanee et dispositif correspondant
US4532089A (en) 1984-01-14 1985-07-30 Northwestern University Method of preparing giant size liposomes
US5077056A (en) 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US5230899A (en) * 1985-08-07 1993-07-27 Smithkline Beecham Corporation Methods and compositions for making liposomes
US5622713A (en) 1985-09-17 1997-04-22 The Regents Of The University Of California Method of detoxifying animal suffering from overdose
DE3765711D1 (de) 1986-07-15 1990-11-29 Fin Omet S R L Methode zum herstellen von handtuechern fuer spender sowie auf diese weise hergestellte handtuecher und dazugehoeriger behaelter.
WO1988001864A1 (en) 1986-09-18 1988-03-24 Liposome Technology, Inc. High-concentration liposome processing method
JPS63211222A (ja) 1987-02-27 1988-09-02 Terumo Corp リポソ−ムの製法
JPH03501732A (ja) 1987-12-22 1991-04-18 ザ　リポソーム　カンパニー，インコーポレイテッド 多重ラメラリポソームの自発的小胞化方法
US5807572A (en) 1988-02-18 1998-09-15 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
DE68901733T2 (de) 1988-03-04 1993-03-25 Takeda Chemical Industries Ltd Liposom-zusammensetzung.
WO1990003808A1 (en) 1988-10-07 1990-04-19 The Liposome Company, Inc. Heat treating liposomes
US5049392A (en) * 1989-01-18 1991-09-17 The Liposome Company, Inc. Osmotically dependent vesicles
US5185154A (en) 1989-02-02 1993-02-09 Liposome Technology, Inc. Method for instant preparation of a drug containing large unilamellar vesicles
DE3913875C1 (https=) 1989-04-27 1990-08-09 Heraeus Quarzschmelze Gmbh, 6450 Hanau, De
EP0472639A4 (en) 1989-05-15 1992-07-01 The Liposome Company, Inc. Accumulation of drugs into liposomes by a proton gradient
JP2880800B2 (ja) 1989-06-22 1999-04-12 ネクスター・フアーマシユーテイカルズ・インコーポレイテツド カプセル化方法
US5039305A (en) 1989-12-18 1991-08-13 Ford Motor Company Multiple ratio compact transaxle assembly for automotive vehicles
US5773024A (en) 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
JP3228957B2 (ja) 1990-06-14 2001-11-12 キヤノン株式会社 巨大リポソームの製造方法及び巨大リポソーム形成用キット
IS1685B (is) 1990-12-11 1998-02-24 Bracco International B.V. Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum
US5327038A (en) 1991-05-09 1994-07-05 Rockwell International Corporation Walking expansion actuator
CA2093381A1 (en) 1992-04-07 1993-10-08 Hideyuki Sawahara Liposome formulation and process for production thereof
JPH06710A (ja) 1992-06-17 1994-01-11 Toshimasu Eguchi 工作機械及びその加工方法
JPH069710A (ja) 1992-06-25 1994-01-18 Canon Inc 巨大リポソームの調製方法、ｌｂ膜製造装置及び該装置を用いたｌｂ膜の製造方法
US5766627A (en) 1993-11-16 1998-06-16 Depotech Multivescular liposomes with controlled release of encapsulated biologically active substances
WO1996032930A1 (en) 1995-04-18 1996-10-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposome drug-loading method and composition
US5686309A (en) * 1996-01-19 1997-11-11 Coulter International Corp. Method and apparatus for determination of hemoglobin content of individual red blood cells
GB9605915D0 (en) 1996-03-21 1996-05-22 Univ Bruxelles Liposome encapsulated amphiphilic drug compositions
US20020136762A1 (en) 1998-01-14 2002-09-26 See Jackie R. Method for inducing a systemic immune response to an antigen
US6106858A (en) 1997-09-08 2000-08-22 Skyepharma, Inc. Modulation of drug loading in multivescular liposomes
US6306432B1 (en) 1997-09-08 2001-10-23 Chiron Corporation High and low load formulations of IGF-I in multivesicular liposomes
CA2304096C (en) 1997-09-18 2003-09-09 Pacira Pharmaceuticals, Inc. Sustained-release liposomal anesthetic compositions
IN190388B (https=) 1997-10-01 2003-07-26 Biomira Usa Inc
CA2298475A1 (en) * 1997-10-31 1999-05-14 Walter Reed Army Institute Of Research Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules
AU752802C (en) 1997-11-14 2006-04-13 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
US20050031679A1 (en) 1998-03-27 2005-02-10 Clemens Unger Method for producing liposomal formulations of active ingredients
IL140892A0 (en) 1998-08-12 2002-02-10 Yissum Res Dev Co Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient
HUP0202475A3 (en) 1999-07-16 2004-06-28 Alza Corp A liposome composition having resistance to freeze/thaw damage
AU2001264079A1 (en) 2000-06-14 2001-12-24 William Leslie Porter Lipids for modulating immune response
AR031744A1 (es) 2001-11-08 2003-10-01 Paoli Tomas De Proliposomas en polvo, un procedimiento para la elaboracion de dichas proliposomas en polvo, procedimiento para la preparacion de una composicion farmaceutica empleando proliposomas en polvo y aparato para ser empleado en el procedimiento de elaboracion de dichas proliposomas en polvo
AU2002340670A1 (en) * 2001-11-13 2003-05-26 Celator Technologies, Inc. Lipid carrier compositions and methods for improved drug retention
JP2005530704A (ja) 2002-03-05 2005-10-13 トランセイブ， インク． 細胞内感染を予防及び治療するための吸入システム
GB0312309D0 (en) * 2003-05-29 2003-07-02 Gaslini Children S Hospital G Targeted liposome
CN101889981A (zh) * 2003-11-20 2010-11-24 Ym生物科学有限公司 包含含有药物成分的亲脂胺的稳定脂质体组合物
EP1547580A1 (en) 2003-12-23 2005-06-29 MediGene Oncology GmbH Loading of a camptothecin drug into colloidal nanoparticles
EP2407169A1 (en) 2004-04-22 2012-01-18 Celator Pharmaceuticals, Inc. Combination formulations of anthracycline agents and cytidine analogs
EP1776948B1 (en) * 2004-08-11 2015-12-09 Konica Minolta Medical & Graphic, Inc. Method of producing liposome-containing preparation
TW200618820A (en) * 2004-11-05 2006-06-16 Alza Corp Liposome formulations of boronic acid compounds
US20060239925A1 (en) * 2005-04-21 2006-10-26 Konica Minolta Medical & Graphic, Inc. Method of manufacturing pharmaceutical preparation containing liposomes
ES2275443B1 (es) 2005-11-30 2008-06-01 Italfarmaco, S.A. Procedimiento de preparacion de liposomas.
JP5484059B2 (ja) 2006-10-06 2014-05-07 エスシーアイエル テクノロジー ゲゼルシャフト ミット ベシュレンクテル ハフツング 脊髄核インプラント
US8071127B2 (en) * 2006-10-24 2011-12-06 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
JP5080779B2 (ja) * 2006-10-25 2012-11-21 テルモ株式会社 リポソーム製剤の製造方法
JP2008136967A (ja) 2006-12-04 2008-06-19 Shinshu Univ リポソームおよびその製造方法
US20090017108A1 (en) 2007-07-11 2009-01-15 Alexander Yuzhakov Liposome compositions for treatment of hepatitis C
CA2697044A1 (en) * 2007-08-21 2009-02-26 Alza Corporation Liposome formulations of boronic acid compounds
WO2009091531A2 (en) 2008-01-16 2009-07-23 The General Hospital Corporation Uniform-sized, multi-drug carrying and photosensitive liposomes for advance drug delivery
EP2253308A1 (en) 2009-05-22 2010-11-24 Ludwig-Maximilians-Universität München Pharmaceutical composition comprising microbubbles for targeted tumor therapy
WO2010138918A1 (en) 2009-05-29 2010-12-02 Pacira Pharmaceuticals, Inc. Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent
JP5771366B2 (ja) 2009-09-02 2015-08-26 株式会社バイオメッドコア リポソーム製造装置及び方法
CA2781527C (en) 2009-09-23 2017-10-24 Indu Javeri Methods for the preparation of liposomes
DK177529B1 (en) * 2009-10-23 2013-09-08 Bio Bedst Aps Liposomes with improved storage stability
US20110250264A1 (en) 2010-04-09 2011-10-13 Pacira Pharmaceuticals, Inc. Method for formulating large diameter synthetic membrane vesicles
EP2394640A1 (en) 2010-05-21 2011-12-14 MediGene AG Improved liposomal formulations of lipophilic compounds
EP2433619A1 (en) 2010-09-24 2012-03-28 Intsel Chimos Novel antitumoral agent and its therapeutic uses
JP5947807B2 (ja) * 2010-12-14 2016-07-06 テクニカル ユニバーシティ オブ デンマークＴｅｃｈｎｉｃａｌ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｄｅｎｍａｒｋ ナノ粒子組成物への放射性核種の封入
TR201911076T4 (tr) * 2011-01-05 2019-08-21 Prenatal Int Gmbh Klorür içeriği azaltılmış fosfolipit içeren veya içermeyen hipotonik sulu bileşim.
JP2012158576A (ja) 2011-02-03 2012-08-23 Yuki Goto 高圧力を利用したリポソームの粒子径制御方法
US8871811B2 (en) 2011-02-07 2014-10-28 Professional Compounding Centers of America, Ltd Permeation enhancers for topical formulations
JP2014101273A (ja) 2011-02-28 2014-06-05 Tokyo Medical And Dental Univ 脂質構造体の製造方法
RU2014133467A (ru) * 2012-02-17 2016-04-10 Селшн Корпорейшн Термочувствительные составы в виде наночастиц и способ их получения
CN102626390B (zh) 2012-04-19 2013-05-29 海南灵康制药有限公司 一种天麻素多相脂质体注射液
CN102716089B (zh) 2012-06-29 2013-12-11 海南灵康制药有限公司 一种盐酸吉西他滨脂质体注射剂
GB201212896D0 (en) 2012-07-20 2012-09-05 European Molecular Biology Lab Embl Giant array liposome for high-throughput lipid-protein interaction screening
EP2695606A1 (en) 2012-08-09 2014-02-12 ETH Zürich Liposome composition for peritoneal dialysis
RU2516893C1 (ru) * 2012-12-14 2014-05-20 Общество с ограниченной ответственностью "Уральский центр биофармацевтических технологий" Липосомальная композиция и способ ее получения
WO2014116866A1 (en) 2013-01-24 2014-07-31 Memorial Sloan Kettering Cancer Center Method for diagnosing or treating tumors using sphingomyelin containing liposomes
CN103182333B (zh) 2013-03-01 2015-07-29 重庆大学 一种脂质体制备和收集装置及方法
AU2016256979B2 (en) * 2015-05-04 2021-01-28 Genfit Method for preparing transmembrane pH-gradient vesicles

Also Published As

Publication number Publication date
US20180104189A1 (en) 2018-04-19
PT3291797T (pt) 2020-10-19
RU2017141919A3 (https=) 2019-09-20
HK1250663A1 (en) 2019-01-11
CN107750156B (zh) 2020-08-21
MX2017014130A (es) 2018-07-06
RU2717824C2 (ru) 2020-03-26
ES2826896T3 (es) 2021-05-19
WO2016177741A1 (en) 2016-11-10
JP2018519370A (ja) 2018-07-19
EP3291797B1 (en) 2020-09-02
US20220287971A1 (en) 2022-09-15
EP3291797A1 (en) 2018-03-14
CA2987844A1 (en) 2016-11-10
JP6715265B2 (ja) 2020-07-01
AU2016256979A1 (en) 2017-12-07
US12427112B2 (en) 2025-09-30
CN107750156A (zh) 2018-03-02
RU2017141919A (ru) 2019-06-04
AU2016256979B2 (en) 2021-01-28
DK3291797T3 (da) 2020-09-21
US11376218B2 (en) 2022-07-05
BR112017023578A2 (pt) 2018-09-04

Similar Documents

Publication Publication Date Title
MX381655B (es) Metodo para preparar vesiculas con gradiente de ph de transmembrana.
CO2020003882A2 (es) Anticuerpo multiespecifico
CL2025001440A1 (es) Medios y método para preparar vectores virales y usos de los mismos
IL288784A (en) Anti-garp antibodies, nucleotides encoding same, vectors, cells and compositions comparising same, methods of producing same and uses thereof
CO2019003154A2 (es) Anticuerpos anti-pd-1 y sus usos
PE20181529A1 (es) Vacunas de acido nucleico para el virus varicela-zoster (vzv)
BR112018070165A2 (pt) métodos, dispositivo sem fio e nó de rede para indicar parâmetros de pré-codificador em uma rede de comunicação sem fio
BR112017009728A2 (pt) anticorpos isolados, ácido nucleico isolado, vetor, célula hospedeira, método para produzir o anticorpo, composição, usos de um anticorpo e métodos de tratamento de um distúrbio
BR112017012927A2 (pt) partícula compósita, processo cosmético e métodos para a preparação de uma partícula compósita
CR20180605A (es) Anticuerpos anti-cd40 y sus usos
BR112018010136A8 (pt) microcápsulas, dispersão de microcápsulas, processo para a preparação das microcápsulas e método para o controle de fungos fitopatogênicos
MX389093B (es) Composiciones y metodos para la glicosilacion de proteinas.
MX391216B (es) Composicion farmaceutica que comprende un vector adenoviral.
ES2721309T3 (es) Composición para preparar tagatosa y método para preparar tagatosa a partir de fructosa
CO2020005371A2 (es) Anticuerpos anti-apoc3 y métodos de uso de estos
EA201992006A1 (ru) Пусковая система и способ повышения эффективности электроантимагнитных пусковых систем
AR127380A2 (es) Método para elaborar una solución acuosa de leucoíndigo libre de anilina o libre de anilina y n-metilanilina, solución estable acuosa de leucoindigo, método para su elaboración, aparato y uso
MX377258B (es) Composiciones de vectores poxvirus y su uso para inducir una respuesta inmunitaria.
MX393656B (es) Metodo para preparar esperma.
EA201990163A1 (ru) Консервация микроорганизмов
MX2018009077A (es) Edulcorante que tiene aumento de resistencia acida de los oligosacaridos, alimentos que contienen estos, y metodo para el aumento de la resistencia acida de los oligosacaridos.
BR112017006533A2 (pt) usos de trealose em suspensões celulares
BR112017003167A2 (pt) método in vitro e aparelho para análise do comportamento de substâncias em ambiente fisiológico simulado
EA201891131A1 (ru) Теплоизоляционные материалы, содержащие сферические и полые неорганические частицы
MX2017011792A (es) Metodo para fabricar acido furan-2,5-dicarboxilico (fdca) a partir de una solucion de sal.